How to develop strategies for improving musculoskeletal health

Best Practice and Research: Clinical Rheumatology

Volumn 21, Issue 1, 2007, Pages 5-25

  Åkesson, Kristina ^a   Woolf, Anthony D ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

evidence based strategies; musculoskeletal health; prevention

Indexed keywords

ALPHA TOCOPHEROL; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; GLUCOSAMINE; MINERAL; MUSCLE RELAXANT AGENT; STEROID; VITAMIN D;

ACCIDENT; ALCOHOL CONSUMPTION; BACKACHE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIFESTYLE; META ANALYSIS; MORBIDITY; MUSCULOSKELETAL INJURY; OBESITY; OCCUPATIONAL ACCIDENT; OSTEOARTHRITIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; RISK MANAGEMENT; SMOKING; SOCIAL CARE; SYSTEMATIC REVIEW;

EUROPE; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HEALTH PROMOTION; HUMANS; LIFE STYLE; MUSCULOSKELETAL DISEASES; POLITICS; RISK ASSESSMENT;

EID: 33847634849     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.10.005     Document Type: Review

References (9)

1. Report of a WHO Scientific Group. The Burden of Musculoskeletal Diseases at the Start of the New Millenium. WHO Technical Report Series No. 919 (2003), World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf Available at:
2. Woolf A.D., and Akesson K. Preventing fractures in elderly people. British Medical Journal 327 7406 (2003) 89-95
3. European Action Towards Better Musculoskeletal Health: A Public Health Strategy to Reduce the Burden of Musculoskeletal Conditions. A Bone and Joint Decade Report, 2004. The European Bone and Joint Health Strategies Project. The Bone and Joint Decade, Lund, Sweden: Available at: http://ec.europa.eu/health/ph_projects/2000/promotion/fp_promotion_2000_frep_15_en.pdf.
4. Connelly L.B., Woolf A.D., and Brooks P. Cost effectiveness of interventions for musculoskeletal conditions. In: Jamison D.T., Bremen J.G., Measham A.R., et al. (Eds). Disease Control Priorities in Developing Countries (2006), The World Bank and Oxford University Press, New York 963-980
5. WHO. The International Classification of Functioning, Disability and Health (ICF) (2001), World Health Organization, Geneva. http://www3.who.int/icf/onlinebrowser/icf.cfm Available at:
6. Cluzeau F.A., Littlejohns P., Grimshaw J.M., et al. Development and application of a generic methodology to assess the quality of clinical guidelines. International Journal for Quality in Health Care 11 1 (1999) 21-28
7. Eccles M., Freemantle N., and Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. British Medical Journal 316 7139 (1998) 1232-1235
8. Anon. Cochrane corner: ecomonics and health care. Bandolier 18 (1995). http://www.jr2.ox.ac.uk/bandolier/band18/b18-4.html Available online at:
9. European Commission. Indicators for Monitoring Musculoskeletal Problems and Conditions. Musculoskeletal Problems and Functional Limitation. The Great Public Health Challenge for the 21st Century. Grant agreement no. (S12.297217) (2003), EC, Bone and Joint Decade, Oslo. Available at: http://ec.europa.eu/health/ph_projects/2000/monitoring/fp_monitoring_2000_frep_01_en.pdf#search=%22Indicators%20for%20Monitoring%20Musculoskeletal%20Problems%20and%20%20%22